These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9160522)

  • 1. The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse.
    Hjorth RN; Bonde GM; Piner ED; Goldberg KM; Levner MH
    Vaccine; 1997 Apr; 15(5):541-6. PubMed ID: 9160522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children.
    Nolan T; Bravo L; Ceballos A; Mitha E; Gray G; Quiambao B; Patel SS; Bizjajeva S; Bock H; Nazaire-Bermal N; Forleo-Neto E; Cioppa GD; Narasimhan V
    Vaccine; 2014 Oct; 32(46):6146-56. PubMed ID: 25223266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
    J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
    Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
    Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
    Ott G; Barchfeld GL; Van Nest G
    Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge.
    Sarkadi J; Kuti D; Jankovics M; Pallinger E; Fodor K; Kis Z; Gonczol E; Visontai I; Jankovics I
    New Microbiol; 2017 Jul; 40(3):180-189. PubMed ID: 28675247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population.
    Atsmon J; Caraco Y; Ziv-Sefer S; Shaikevich D; Abramov E; Volokhov I; Bruzil S; Haima KY; Gottlieb T; Ben-Yedidia T
    Vaccine; 2014 Oct; 32(44):5816-23. PubMed ID: 25173483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera].
    Kozlov VG; Viktorova EG
    Vopr Virusol; 2011; 56(2):41-6. PubMed ID: 21545042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
    Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
    Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Silveira F; Rivera-Patron M; Deshpande N; Sienra S; Checa J; Moreno M; Chabalgoity JA; Cibulski SP; Baz M
    Front Immunol; 2023; 14():1163858. PubMed ID: 37197659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses induced by prototype vaccines for AIDS in rhesus monkeys.
    Ohkawa S; Wilson LA; Larosa G; Javaherian K; Martin LN; Murphey-Corb M
    AIDS Res Hum Retroviruses; 1994 Jan; 10(1):27-38. PubMed ID: 8179961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic vaccine against influenza with built-in adjuvanticity.
    Shapira M; Jolivet M; Arnon R
    Int J Immunopharmacol; 1985; 7(5):719-23. PubMed ID: 4044097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
    Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
    Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
    Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
    Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.
    Frey SE; Reyes MR; Reynales H; Bermal NN; Nicolay U; Narasimhan V; Forleo-Neto E; Arora AK
    Vaccine; 2014 Sep; 32(39):5027-34. PubMed ID: 25045825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    van de Witte S; Nauta J; Montomoli E; Weckx J
    Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection.
    Masihi KN; Lange W; Schwenke S; Gast G; Huchshorn P; Palache A; Masek K
    Vaccine; 1990 Apr; 8(2):159-63. PubMed ID: 2336875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.